Black fungus is the common name for mucormycosis, a rare but aggressive fungal infection caused by molds belonging to a group called Mucorales. These molds are ubiquitous in the environment, living in soil, decaying organic matter, and even household dust, yet they almost never cause disease in healthy people. When they do infect someone, the results can be devastating: the fungus invades blood vessels, cuts off blood supply to surrounding tissue, and causes rapid tissue death. Mortality rates exceed 30 to 50 percent for invasive forms of the disease, climbing to around 90 percent when it spreads throughout the body.1PubMed. Mucormycosis The infection grabbed worldwide headlines during India’s devastating second wave of COVID-19 in 2021, but it existed long before the pandemic and continues to affect vulnerable patients around the world.
What Causes It and How People Get Infected
The fungi responsible for mucormycosis belong to several genera, with Rhizopus, Mucor, and Cunninghamella among the most commonly implicated.2PubMed Central. The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance These molds produce vast quantities of spores that float through the air, settle on surfaces, and mix into soil. People inhale them regularly without consequence. The spores can also enter the body through breaks in the skin or, less commonly, through contaminated food.3PubMed Central. Zygomycetes in human disease
In a person with a functioning immune system, white blood cells and other defenses rapidly neutralize these spores before they can germinate and grow. The trouble starts when those defenses are compromised. In someone whose immune system is weakened or whose body chemistry has shifted in certain ways, the spores can germinate into hyphae, the thread-like filaments that let fungi invade tissue. Mucorales species are especially drawn to blood vessels. Once the fungal filaments penetrate the walls of blood vessels, they block blood flow and cause the surrounding tissue to die, turning it black. That necrotic appearance is what gave the infection its grim nickname.
Research has uncovered some of the molecular details behind this invasion. A protein on the surface of human cells, called GRP78, acts as a kind of unwitting doorway. The fungal spores carry surface proteins (CotH proteins) that latch onto GRP78, allowing the fungus to enter and damage the cells lining blood vessels and nasal passages.4PubMed Central. CotH3 mediates fungal invasion of host cells during mucormycosis In laboratory studies, when researchers made yeast cells express these CotH proteins, the yeast gained the ability to invade human cells, confirming that CotH is a key part of the infection machinery.5PubMed Central. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis GRP78 is found at higher levels on nasal epithelial cells, which helps explain why the sinuses are so often the starting point of infection.
Who Is Most at Risk
Mucormycosis is overwhelmingly a disease of people with compromised defenses. In wealthier countries, it appears most often in patients who are severely immunosuppressed, such as those being treated for blood cancers, organ transplant recipients on anti-rejection drugs, or people with prolonged periods of very low white blood cell counts.6PubMed. Mucormycosis Only about 6 to 10 percent of cases in these settings occur in people with no identifiable underlying condition.7PubMed. Mucormycosis
In lower-income countries, the picture looks different. Uncontrolled diabetes is the dominant risk factor, and otherwise healthy people who suffer major traumatic injuries, including burns, can also develop the infection.8New England Journal of Medicine. Mucormycosis Diabetic ketoacidosis, a dangerous complication of diabetes in which the blood becomes acidic, creates a particularly hospitable environment. The acid conditions release iron from the proteins that normally keep it locked away in the bloodstream. Mucorales species thrive on free iron, using it to fuel their growth.9Molecular Biology Reports. COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression At the same time, high blood sugar and acidosis impair the ability of white blood cells to kill fungal spores, effectively disarming the body’s first line of defense.10Clinical Epidemiology and Global Health. Mucormycosis: A deadly black fungus infection among COVID-19 patients in India
The full list of predisposing conditions is long and reflects anything that suppresses immune function or disrupts normal body chemistry:
- Uncontrolled diabetes: especially with ketoacidosis
- Blood cancers and chemotherapy: which deplete white blood cells
- Organ transplantation: requiring long-term immunosuppressive drugs
- Corticosteroid use: which broadly dampens immune responses
- Severe trauma or burns: which breach the skin barrier
- Iron overload therapies: particularly deferoxamine, which provides iron to the fungus in a form it can readily use
- HIV infection and kidney failure: both of which weaken immunity
Steroid use, in particular, became a flashpoint during the COVID-19 pandemic.11PubMed Central. Invasive fungal infections and the management in immunocompromised conditions
Why COVID-19 Triggered an Explosion of Cases
India had always accounted for a disproportionate share of the world’s mucormycosis cases, largely because of its high prevalence of diabetes, including many undiagnosed cases. But the second wave of COVID-19 in early 2021 produced a surge so dramatic it made international news. Thousands of cases were reported over just a few months, an “unusually high number” that could not be explained by background rates alone.12Clinical Infectious Diseases. Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease
Several risk factors aligned simultaneously. COVID-19 itself causes immune dysregulation, making patients more vulnerable to secondary infections. Critically ill patients received high doses of corticosteroids like dexamethasone, which saved lives by taming the inflammatory storm of severe COVID but simultaneously suppressed the immune defenses that keep fungi at bay. The virus also pushed blood sugar out of control in many patients, even those who had not previously been diabetic. A case-control study found that new-onset diabetes carried by far the highest risk, with nearly 49 times the odds of developing COVID-associated mucormycosis compared to non-diabetic patients. Pre-existing diabetes roughly tripled the odds, while corticosteroid therapy nearly quadrupled them.13Medical Mycology. Risk factors for COVID-19 associated mucormycosis in India: A case control study
Beyond the patient’s own body, environmental factors also played a role. Prolonged hospitalization, use of ventilators, and even contaminated or poorly maintained humidifiers on oxygen cylinders created ideal conditions for fungal spore exposure.14PubMed Central. Five probable factors responsible for the COVID-associated mucormycosis outbreak in India Patients recovering in home isolation also faced elevated risk, possibly because of unsterilized oxygen equipment and less medical monitoring of their blood sugar and steroid doses.15Medical Mycology. Risk factors for COVID-19 associated mucormycosis in India: A case control study
How the Disease Presents Itself
Mucormycosis takes several forms depending on where the fungus gains its foothold, and the symptoms vary accordingly. The most common and most recognizable is the rhino-orbito-cerebral form, which starts in the sinuses and can spread to the eye sockets and brain. The second most common presentation is pulmonary (lung) mucormycosis. It can also appear as a skin infection, a gastrointestinal infection, or, in the worst cases, a disseminated infection that spreads throughout the body.16Infection. Pulmonary mucormycosis: clinical features and outcomes
The Rhino-Orbito-Cerebral Form
This is what most people picture when they hear “black fungus.” It typically begins with symptoms that mimic a sinus infection: facial pain, nasal congestion, and fever. The warning sign that distinguishes it is rapid worsening and the appearance of blackened tissue, usually visible on the palate (roof of the mouth) or inside the nose, where dead tissue takes on a dark, eschar-like appearance.17PubMed Central. Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases
If the infection is not caught early, it spreads relentlessly. From the ethmoid sinus, it can break through the thin bone wall into the eye socket, affecting the muscles that move the eye and eventually the optic nerve. Double vision and inability to move the eye can be among the first signs that the infection has reached the orbit.18PubMed. Rhino-orbital-cerebral mucormycosis From the maxillary sinus, the fungus can erode downward into the palate, creating a painful black ulcer in the mouth. In the worst trajectory, it reaches the brain by invading veins that drain into the cavernous sinuses at the skull base. Once it enters the brain, survival rates plummet.19PubMed. Rhino-orbital-cerebral mucormycosis
Pulmonary and Other Forms
Pulmonary mucormycosis often presents with persistent fever, cough, chest pain, and sometimes coughing up blood. It is most common in patients with blood cancers or severely suppressed immune systems. Because the symptoms overlap heavily with other lung infections, particularly invasive aspergillosis, it can be difficult to diagnose without tissue samples. Cutaneous mucormycosis, meanwhile, typically follows a traumatic wound or burn that becomes contaminated with fungal spores. It tends to be more localized and carries lower mortality than other forms, with death rates in the range of 10 to 30 percent for localized skin disease compared to over 50 percent for invasive cases.20PubMed. Mucormycosis
Why Diagnosis Is So Difficult
One of the most frustrating aspects of mucormycosis is that it is hard to confirm in the lab. The gold standard is still examining a tissue biopsy under a microscope, where the characteristic broad, ribbon-like fungal filaments with few internal dividing walls can be seen. But getting a positive culture from tissue samples is unreliable. In one study, the sensitivity of tissue culture was only 70 percent, and blood cultures were uniformly negative.21PubMed Central. Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens The reasons are instructive: the large, fragile hyphae can be destroyed during the grinding process used to prepare samples, the infected tissue is often necrotic and contains few viable organisms, and patients may have already received antifungal treatment that kills the fungus before it can be cultured.22PubMed Central. Comparison of histopathological analysis, culture and polymerase chain reaction assays to detect mucormycosis in biopsy and blood specimens
Molecular techniques like PCR (which amplifies tiny amounts of fungal DNA to detectable levels) show promise for improving detection. Meta-analyses suggest PCR outperforms conventional microscopy, culture, and most blood-based tests in sensitivity.23PubMed Central. The Molecular Diagnosis of Invasive Fungal Diseases with a Focus on PCR Still, these methods are not yet widely standardized or available in many of the settings where mucormycosis is most common. The practical result is that doctors often need to begin treatment based on clinical suspicion, imaging findings, and biopsy appearance, even without a definitive culture-confirmed diagnosis. Samples from suspected cases frequently fail to grow Mucorales in standard lab conditions.24PubMed Central. Molecular methods to improve diagnosis and identification of mucormycosis
Treatment Requires Both Drugs and Surgery
Treating mucormycosis effectively demands a two-pronged approach: antifungal medication and aggressive surgical removal of infected tissue. Neither alone is sufficient in most cases.
The primary antifungal is amphotericin B, specifically its liposomal formulation, which remains the gold standard.25PubMed Central. Adverse Drug Reaction of Antifungals in the Management of Black Fungus: A Tertiary Care Centre Experience The older deoxycholate formulation of amphotericin B is similarly effective but carries higher risks of kidney damage and electrolyte disturbances, so the liposomal version is preferred whenever available. Isavuconazole, a newer antifungal approved for treatment of both invasive aspergillosis and mucormycosis, offers the advantage of oral dosing and more predictable drug levels in the body, making it useful as a step-down therapy or an alternative for patients who cannot tolerate amphotericin B.26PubMed Central. Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
Surgery, however, is where the real battle is often fought. Because the fungus destroys blood supply to the tissue it invades, antifungal drugs delivered through the bloodstream may not reach the dead zones where the fungus is most concentrated. Surgeons need to cut away all visibly infected and necrotic tissue, sometimes returning multiple times for repeated debridement as the extent of infection becomes clearer. In a three-year study of patients with the rhino-orbito-cerebral form, all received intravenous liposomal amphotericin B and endoscopic sinus surgery, with the majority also receiving direct injections of amphotericin B behind the eye.27Scientific Reports. Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study In roughly 8 percent of cases in that study, the eye had to be removed entirely (orbital exenteration) to control the spread of infection.28Scientific Reports. Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study
The outcomes without prompt treatment are grim. In a retrospective series of 11 patients who presented with advanced orbital involvement, all received intravenous amphotericin B and nine underwent surgical debridement, yet only three survived.29PubMed Central. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially Speed matters enormously. Controlling the underlying risk factor, whether that means getting blood sugar under control, reducing steroid doses, or restoring immune function, is just as important as the antifungal treatment itself.
Living After Mucormycosis
Surviving mucormycosis is not the end of the story. The aggressive surgical debridement that saves lives often leaves patients with major anatomical deficits. People who have undergone treatment for the rhino-orbito-cerebral form may be left with large holes in the palate, missing portions of the cheekbone or upper jaw, and, if the eye was removed, an empty orbit. These defects can impair breathing, eating, speaking, and appearance.30PubMed Central. Reconstruction in Rhino-Orbito-Cerebral Mucormycosis Survivors: A Systematic Review
Reconstruction is possible but complex. Surgeons may use tissue flaps, prosthetic devices, or a combination of both to restore function. An obturator prosthesis, essentially a custom-fitted plate, can close a palatal defect and restore the ability to eat and speak. When part of the upper jaw has been removed, specialized implants anchored into the cheekbone (zygomatic implants) offer one approach to rebuilding dental function, since the necrotic maxillary bone left after the infection is often too damaged to support conventional implants.31PubMed Central. Zygomatic Implants for the Rehabilitation of Maxillary Defects Post-Mucormycosisy: A Systematic Review For patients who lost an eye, reconstruction aims to create a socket that can support a realistic prosthetic eye. The functional goals are clear: restore nasal breathing, enable eating by mouth, and produce understandable speech. The aesthetic goal is a socially acceptable appearance that lets the person re-enter daily life.
Prevention in Hospitals and Beyond
Because Mucorales spores are everywhere in the environment, complete avoidance is impossible. Prevention efforts focus instead on reducing exposure for the most vulnerable patients and managing the underlying conditions that make infection possible.
In hospital settings, the standard approach for protecting high-risk patients, especially those with very low white blood cell counts, involves high-efficiency air filtration systems and careful infection control during any nearby construction, which can stir up enormous quantities of fungal spores from dust and building materials.32PubMed. A Pragmatic Approach to Investigating Nosocomial Acquisition of Rare and Emerging Molds Maintaining clean and sterile oxygen delivery equipment is another practical measure that received renewed attention after the COVID-19 mucormycosis wave.
For individuals, the most actionable preventive step is managing the conditions that make the infection possible in the first place. If you have diabetes, tight blood sugar control is the single most important thing you can do. Steroids should be used at the lowest effective dose and for the shortest time possible. People who are immunosuppressed and who work in environments with heavy soil exposure, such as gardening or construction, should consider wearing masks to limit spore inhalation, though no mask perfectly filters every spore. The uncomfortable reality is that some patients have risk factors they cannot fully eliminate. For them, the best defense is awareness: knowing that persistent sinus symptoms, facial swelling, dark discoloration in the mouth or nose, or sudden vision changes in the setting of diabetes or immunosuppression are warning signs that demand urgent medical evaluation rather than a wait-and-see approach.
An Unexpected Lab Finding About Statins
One piece of research that caught attention in the mucormycosis field involves statins, the cholesterol-lowering drugs taken by hundreds of millions of people worldwide. In lab experiments, exposing Rhizopus oryzae (one of the main species responsible for mucormycosis) to statins reduced the fungus’s ability to form the germlings that initiate tissue invasion, induced DNA damage in the fungal cells, and reduced the damage those cells inflicted on human blood vessel lining.33PubMed Central. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae These effects occurred at statin concentrations below what would be needed to directly kill the fungus, suggesting that statins might weaken Mucorales virulence rather than acting as conventional antifungals.
This is interesting but early-stage work, done in cell cultures rather than in patients. Whether statin use in diabetic patients coincidentally provides any real-world protection against mucormycosis has not been established in clinical trials. It does, however, point to a broader theme in mucormycosis research: many of the molecular targets being explored for future therapies, including the CotH-GRP78 interaction, are highly specific to Mucorales. If drugs can be designed to block the fungus’s ability to latch onto blood vessel cells or to hijack the body’s iron supply, they could offer more targeted alternatives or supplements to the blunt-instrument toxicity of amphotericin B. For now, that remains a promise rather than a clinical reality.